SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-033543
Filing Date
2022-11-23
Accepted
2022-11-23 16:05:35
Documents
14
Period of Report
2022-11-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43067
2 ex99-01.htm EX-99.01 19627
3 ex99-01_001.jpg GRAPHIC 2387
  Complete submission text file 0001493152-22-033543.txt   246353

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pali-20221123.xsd EX-101.SCH 3236
5 XBRL LABEL FILE pali-20221123_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pali-20221123_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3613
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 221416366
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences